106.818 articles found

Pulmonary function and cardiorespiratory fitness in idiopathic Parkinson's disease

O'Callaghan AK.

· 2018-01-01

The involvement of the pedunculopontine nucleus in Parkinson's disease and the potential for its targeting by deep brain stimulation

Sharma PK.

· 2018-01-01

DOI: 10.25560/80369

CADTH Canadian Drug Expert Committee Recommendation: Apomorphine Hydrochloride (Movapo — Paladin Labs Inc.): Indication: Parkinson’s disease

Check source for author details

· 2018-01-01

PMID: 30427627

Delta Opioid Pharmacology in Parkinson's Disease.

Mabrouk OS.

Handb Exp Pharmacol · 2018-01-01

DOI: 10.1007/164_2016_16PMID: 27718057

Intraoperative Mania During Deep Brain Stimulation for Parkinson Disease.

Venkataramaiah S, Yadav R, Srinivas D, Varadarajan B, Pal P.

J Neurosurg Anesthesiol · 2018-01-01

DOI: 10.1097/ana.0000000000000393PMID: 27875484

Levodopa in Parkinson's Disease: Current Status and Future Developments.

Tambasco N, Romoli M, Calabresi P.

Curr Neuropharmacol · 2018-01-01

DOI: 10.2174/1570159x15666170510143821PMID: 28494719

Effects of Transcranial Direct Current Stimulation Plus Physical Therapy on Gait in Patients With Parkinson Disease: A Randomized Controlled Trial.

Yotnuengnit P, Bhidayasiri R, Donkhan R, Chaluaysrimuang J, Piravej K.

Am J Phys Med Rehabil · 2018-01-01

DOI: 10.1097/phm.0000000000000783PMID: 28650857

Nanodelivery of Cerebrolysin and Rearing in Enriched Environment Induce Neuroprotective Effects in a Preclinical Rat Model of Parkinson's Disease.

Requejo C, Ruiz-Ortega JA, Cepeda H, Sharma A, Sharma HS, Ozkizilcik A, Tian R, Moessler H, Ugedo L, Lafuente JV.

Mol Neurobiol · 2018-01-01

DOI: 10.1007/s12035-017-0741-xPMID: 28840482

Deleterious Effects of VEGFR2 and RET Inhibition in a Preclinical Model of Parkinson's Disease.

Requejo C, Ruiz-Ortega JA, Bengoetxea H, Bulnes S, Ugedo L, Lafuente JV.

Mol Neurobiol · 2018-01-01

DOI: 10.1007/s12035-017-0733-xPMID: 28840516

Relations between Sensorimotor Integration and Speech Disorders in Parkinson's Disease.

Millian-Morell L, Lopez-Alburquerque T, Rodriguez-Rodriguez A, Gomez-Nieto R, Carro J, Meilan JJG, Martinez-Sanchez F, Sancho C, Lopez DE.

Curr Alzheimer Res · 2018-01-01

DOI: 10.2174/1567205014666170829103019PMID: 28847285

Alzheimer's Disease and Parkinson's Disease: A Review of Current Treatment Adopting a Nanotechnology Approach.

Trompetero A, Gordillo A, Del Pilar MC, Cristina VM, Bustos Cruz RH.

Curr Pharm Des · 2018-01-01

DOI: 10.2174/1381612823666170828133059PMID: 28847307

Novel use of levodopa in human immunodeficiency virus encephalopathy-mediated parkinsonism in an adult.

Devine MF, Herrin C, Warnack W, Dubey D.

J Postgrad Med · 2018-01-01

DOI: 10.4103/jpgm.jpgm_674_16PMID: 28862245